Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment Article

Passiglia, F, Caglevic, C, Giovannetti, E et al. (2018). Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment . 52 259-268. 10.1016/j.semcancer.2018.01.015

Open Access International Collaboration

cited authors

  • Passiglia, F; Caglevic, C; Giovannetti, E; Pinto, JA; Manca, P; Taverna, S; Listi, A; Gil-Bazo, I; Raez, LE; Russo, A; Rolfo, C

sustainable development goals

authors

publication date

  • October 1, 2018

webpage

keywords

  • Biomarkers
  • Brain
  • CELL LUNG-CANCER
  • CTLA4
  • EXTRACELLULAR VESICLES
  • IMMUNE CHECKPOINT INHIBITION
  • Immunotherapy
  • LIGAND 1 EXPRESSION
  • LIQUID BIOPSY
  • Life Sciences & Biomedicine
  • MELANOMA PATIENTS
  • Metastasis
  • OPEN-LABEL
  • Oncology
  • PD-1 BLOCKADE
  • PD1/PDL1
  • RADIATION-THERAPY
  • Science & Technology
  • TUMOR-INFILTRATING LYMPHOCYTES

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD

start page

  • 259

end page

  • 268

volume

  • 52